OrbiMed’s Augmedix, Inc. Common Stock AUGX Stock Holding History

OrbiMed’s Portfolio AUGX Stock Details AUGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-88,363	Closed	-$278K	–	166
2021 Q4	$278K	Buy	+88,363	New	+$320K	﹤0.01%	157

Other funds holding AUGX

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

DIV

DCM International VI Menlo Park, California $114M AUM 73.96% 1-Year Est. Return

MAG

Millrace Asset Group Berwyn, Pennsylvania $98.4M AUM 63.71% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AFG

American Financial Group Cincinnati, Ohio $270M AUM 3.25% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

Samjo Capital New York $254M AUM 36.81% 1-Year Est. Return

TownSquare Capital Provo, Utah $444M AUM 24.03% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

OrbiMed's AUGX Position: Q1 2022 in Review

OrbiMed sold out of Augmedix, Inc. Common Stock (AUGX) in Q1 2022, closing a stake of 88,363 shares — an estimated $278K sold.

OrbiMed first reported a position in AUGX in Q4 2021 and held it in 1 quarter. The position peaked at $278K in Q4 2021. 22 funds tracked by Wall St. Rank hold AUGX as of Q1 2022.

OrbiMed reported no remaining Augmedix, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
OrbiMed sold 88,363 Augmedix, Inc. Common Stock shares in Q1 2022, an estimated $278K.
OrbiMed first reported a position in Augmedix, Inc. Common Stock in Q4 2021 and held it in 1 quarter.
OrbiMed's Augmedix, Inc. Common Stock position peaked at $278K in Q4 2021.
22 funds tracked by Wall St. Rank held Augmedix, Inc. Common Stock as of Q1 2022.

Based on OrbiMed's 13F filing for Q1 2022, filed 16 May 2022.